Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE - CorMedix Inc. | crmd_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of
report (Date of earliest event reported): May 10, 2017
CORMEDIX
INC.
|
||
(Exact
Name of Registrant as Specified in Charter)
|
Delaware
|
001-34673
|
20-5894890
|
(State
or Other Jurisdictionof Incorporation)
|
(CommissionFile
Number)
|
(IRS
EmployerIdentification No.)
|
1430
U.S. Highway 206, Suite 200, Bedminster NJ
|
07921
|
|
(Address
of Principal Executive Offices)
|
(Zip
Code)
|
Registrant’s
Telephone Number, Including Area Code: (908) 517-9500
|
(Former
Name or Former Address, If Changed Since Last Report)
|
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions (see General Instruction A.2.
below):
☐
Written
communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
☐
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
☐
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))
☐
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))
Item 2.02.
Results of Operations and Financial Condition.
On May 10, 2017, CorMedix Inc. issued a
press release announcing its operating results for the first
quarter ended March 31, 2017. A copy
of the press release is attached hereto as Exhibit 99.1 and is
incorporated herein in its entirety by
reference.
The
information in this Item 2.02 (including Exhibit 99.1) shall not be
deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934 (the “Exchange Act”) or
otherwise subject to the liabilities of that section, nor shall it
be deemed incorporated by reference in any filing under the
Securities Act of 1933 or the Exchange Act, except as expressly set
forth by specific reference in such a filing.
Item 9.01. Financial Statements and
Exhibits.
(d)
Exhibits
Exhibit No.
|
|
Description
|
|
|
|
|
Press release dated May 10,
2017.
|
2
Pursuant to the
requirements of the Securities Exchange Act of 1934, the registrant
has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
CORMEDIX INC. |
|
|
|
|
|
|
Date: May 10,
2017
|
By:
|
/s/
Robert
W. Cook
|
|
|
|
Name:
Robert
W. Cook
|
|
|
|
Title:
Chief
Financial Officer
|
|
3